News

January 14, 2020January 14, 2020

Meta-Analysis Identifies Risk Factors for Post-Thymectomy Myasthenia Crisis

News

A recent meta-analysis has identified factors that put patients with myasthenia gravis at risk for complications following surgery to remove their thymus. These factors include having generalized myasthenia gravis ... Read more

January 7, 2020January 7, 2020

Activation of Natural Killer Cells May Help Control MG, Rat Study Suggests

News

A type of immune cells called natural killer (NK) cells may be able to reduce symptoms of myasthenia gravis (MG) by regulating other components of the immune system, a ... Read more

January 2, 2020January 2, 2020

Side Effects of MG Medications Highlight Need for More Tolerable Treatment Options, Study Suggests

News

Treatments conventionally used for myasthenia gravis (MG) can produce side effects that negatively impact the daily lives of patients and may deter them from taking their medications properly, according ... Read more

December 19, 2019January 4, 2020

Treatments Promoting AChR Clusters May Be New Therapeutic Approach in MuSK-MG

News

Treatments promoting the formation of acetylcholine receptor (AChR) clusters could represent a new therapeutic approach for people with MuSK-autoantibody positive myasthenia gravis (MuSK-MG), a preclinical study suggests. While the data still ... Read more

December 17, 2019December 17, 2019

Vaccine-preventable Infections, Certain Medications Linked to MG Crises

News

The majority of myasthenia gravis (MG) acute exacerbations are associated with infections or with certain medications, a recent study suggests. These findings suggest that patients on certain medications, such ... Read more

December 12, 2019December 12, 2019

Certain Antibodies Increase Risk of Ocular MG Progressing to Generalized Disease, Study Finds

News

In people with ocular myasthenia gravis, the presence of anti-AChR or anti-MuSK antibodies likely increases their risk of disease generalization to the rest of the body, according to a ... Read more

December 10, 2019December 11, 2019

Late-onset MG Found Primarily in Men, Responds Well to Prednisone With Azathioprine, Study Finds

News

Most patients with late-onset myasthenia gravis (LOMG) — those whose disease appears at age 50 or later and is not related to tumors in the thymus gland — are ... Read more

December 5, 2019December 5, 2019

HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases

News

Despite skyrocketing healthcare costs, President Trump is committed to protecting the 30 million or so Americans with rare diseases and ensuring timely, affordable access to lifesaving treatments, the nation’s ... Read more

December 5, 2019December 5, 2019

MG Complicated by Thymus Tumor and Immunodeficiency Should be Treated with Caution, Case Report Warns

News

A rare case of myasthenia gravis (MG) complicated by a tumor in the thymus and an immunodeficiency known as Good syndrome has been documented by researchers, who warn against ... Read more

December 3, 2019December 3, 2019

Cyclophosphamide May Be Low-cost Option for Refractory Patients, Study Says

News

Cyclophosphamide, a medicine with immunosuppressant abilities, may be a potential short-term alternative treatment for refractory — or difficult to treat — myasthenia gravis (MG), especially in lower-income countries, a ... Read more

Pin It on Pinterest